Analytical Data
-
基因名
HDAC6
- Application
-
别名
HD6; JM21
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UBN7
-
表达区间
Ser479~Arg835
-
分子量
70kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Histone deacetylase 6 (HDAC6) is a unique member of the HDAC family, notable for its dual function as both a histone deacetylase and a cytoplasmic enzyme involved in various non-histone protein deacetylation processes. This enzyme primarily localizes in the cytoplasm, where it plays critical roles in regulating cellular functions such as protein degradation, cell migration, and immune responses. HDAC6 has been implicated in several diseases, including cancer, neurodegenerative disorders, and inflammation, making it a promising therapeutic target. Recent studies have highlighted its role in the acetylation status of key proteins involved in microtubule dynamics, such as tubulin and Hsp90, which are crucial for cellular homeostasis. The ability of HDAC6 to regulate the acetylation of non-histone substrates has spurred interest in developing small-molecule inhibitors that could selectively target HDAC6 for potential therapeutic applications. Understanding the structural and functional properties of HDAC6 through recombinant protein studies is vital for elucidating its mechanisms of action and for the design of effective HDAC6 modulators. Thus, research into HDAC6 recombinant proteins not only enhances our knowledge of its biological functions but also paves the way for innovative strategies to combat diseases associated with dysregulated HDAC6 activity.












